← All trials
NCT04288102
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 28, 2020
- Primary completion
- Dec 31, 2020
- Completion date
- Dec 31, 2021
- First posted
- Feb 28, 2020
- Last posted
- Feb 28, 2020
- Enrollment
- 45
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- People's Liberation Army of ChinaLead sponsor
- Huazhong University of Science and TechnologyCollaborator
- Sichuan UniversityCollaborator
- Tianjin UniversityCollaborator
- Sun Yat-Sen UniversityCollaborator
- People's Liberation Army of ChinaReponsible party - principal investigator
- Shenzhen Third People's HospitalCollaborator
- People's Liberation Army of ChinaStudy chair
- Wuhan Huoshenshan HospitalCollaborator
- Zhongyuan Union Stem Cell Bio-engineering CorporationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.